Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol’s Cost and Treatment Outcomes Registry

Saxon AJ, Akerman SC, ChihChin L, Sullivan MA, Silverman BL, Vocci FJ (2019). Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol’s Cost and Treatment Outcomes Registry Addiction 113(8): 1477-1487, 2018. DOI:10.1111/add.14199.